Results 11 to 20 of about 561 (202)
Hereditary angioedema type III (estrogen-dependent) report of three cases and literature review* [PDF]
Anais Brasileiros de Dermatologia, 2013 In this article, three cases of hereditary angioedema (HAE) type III (estrogen-dependent or with normal C1 inhibitor) are reported. The HAE was initially described in women of the same family in association with high-leveled estrogenic conditions such as
Amanda Rodrigues Miranda +5 more
doaj +1 more source
Cureus, 2023 The authors present the case of a 22-year-old female who reported having a persistent sore throat. The patient had a history of recurring episodes of hereditary angioedema and arrived at the emergency department with her C1-esterase inhibitor. The epidemiology, clinical presentation, and treatment strategies are presented.
Banerjee, Anjali +4 more
openaire +2 more sources
Physician awareness and understanding of hereditary angioedema: A web‐based study in Japan
Journal of Cutaneous Immunology and Allergy, 2022 Objectives Hereditary angioedema (HAE) is a rare disease with acute attacks in the skin and mucosa throughout the body including life‐threatening laryngeal edema and abdominal attacks with severe pain.
Atsushi Fukunaga +6 more
doaj +1 more source
Frontiers in Immunology, 2021 It has been hypothesized that low levels of C1 esterase inhibitor (C1-INH), a key inhibitor of the complement pathway, may play a role in the occurrence of adverse events (AEs) associated with intravenous immunoglobulin (IVIG) therapy.
Isaac R. Melamed +3 more
doaj +1 more source
Screening for Plasminogen Mutations in Hereditary Angioedema Patients
, 2021 Hereditary angioedema (HAE) is a rare disease belonging to the group of bradykinin-mediated angioedemas, characterized by recurring edematous episodes involving the subcutaneous and/or submucosal tissues.
Edina Szabó +4 more
core +1 more source
Treatment of Hereditary Angioedema [PDF]
Journal of Investigational Allergology and Clinical Immunology, 2021 Hereditary angioedema due to C1-esterase inhibitor deficiency (C1-INH-HAE) is a rare autosomal dominant disease. In the last decade, new drugs and new indications for old drugs have played a role in the management of C1-INH-HAE. This review examines current therapy for C1-INH-HAE and provides a brief summary of drugs that are under development ...
openaire +2 more sources
Pathophysiology of Hereditary Angioedema [PDF]
Pediatric Allergy, Immunology, and Pulmonology, 2014 The genetic deficiency of the C1 inhibitor is responsible for hereditary angioedema (HAE), which is a disease transmitted as an autosomal dominant trait. More than 200 point mutations in the C1 inhibitor gene have been found to be associated with HAE. Patients with this disease suffer from recurrent angioedema, which is mediated by bradykinin derived ...
S. Caccia, C. Suffritti, M. Cicardi
openaire +2 more sources
Optimum Use of Acute Treatments for Hereditary Angioedema: Evidence-Based Expert Consensus
Frontiers in Medicine, 2018 Acute treatment of hereditary angioedema due to C1 inhibitor deficiency has become available in the last 10 years and has greatly improved patients’ quality of life.
Hilary Longhurst
doaj +1 more source
Acta Médica Portuguesa, 2019 Introduction: Hospitalizations due to angioedema are important especially in debilitating or life-threatening situations. The aim of this study was to evaluate the frequency and etiology of angioedema without urticaria in hospital admissions.
Joana Cosme +3 more
doaj +1 more source
Anais Brasileiros de Dermatologia, 2012 Hereditary Angioedema is a dominantly inherited disease. Routine screening of autoantibodies (AAB) is not recommended for individuals with Hereditary Angioedema; however, prevalence of these antibodies in Hereditary Angioedema patients is not well ...
Sergio Duarte Dortas Junior +7 more
doaj +1 more source